相关实验视频

Updated: Jan 17, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

帕金森病中轻度认知障碍的危险因素:系统性审查和元分析

Yaodan Zhang¹, Fang Chen², Fengchun Ren³

¹Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Molecular and cellular biochemistry

|September 17, 2025

概括

帕金森病 (PD) 中的轻度认知障碍 (MCI) 与年龄较大,晚发和持续时间较长有关. 高等教育提供了保护,而疾病的严重程度增加了风险.

科学领域:

神经学神经学
神经科学是一个神经科学.
老年病的医生老年病的医生

背景情况:

轻度认知障碍 (MCI) 是帕金森病 (PD) 中普遍存在的非运动性症状,通常是痴呆症的前身.
对于PD中MCI的风险因素并未一致确定,需要进行全面的分析.

研究的目的:

进行系统性审查和元分析,以确定帕金森病中MCI的人口和临床风险因素.
综合现有数据,以便更清楚地了解PD患者的MCI决定因素.

主要方法:

按照PRISMA指南进行系统审查和元分析.
使用MeSH术语和关键词搜索电子数据库,由独立审核人员进行多步查询.
使用纽卡斯尔-太华尺度进行数据提取和质量评估;使用综合元分析 (v2) 进行的元分析.

主要成果:

年龄较大,PD发病时间较晚,疾病持续时间较长是MCI的重要风险因素.
更高的教育程度表明,在PD中对MCI有保护作用.
增加的疾病严重程度 (UPDRS,Hoehn和Yahr尺度) 与较高的MCI风险有显著的关联;性别不是一个重要的因素.

结论:

晚年,晚期的疾病发作,更长的疾病持续时间和更大的PD严重程度是MCI的关键决定因素.
这些发现强调了早期检测和主动治疗帕金森病中MCI的战略的重要性.
识别这些风险因素可以帮助指导PD患者的临床决策和干预措施.

关键词:

进行元分析分析.轻度认知障碍轻度认知障碍帕金森氏症帕金森氏症风险因素风险因素

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....